子どもの心の診療シリーズ　4　子どもの不安障害と抑うつ

出版社： 中山書店
著者：
発行日： 2010-09-10
分野： 臨床医学：内科  >  小児科学一般
ISBN： 9784521731490
シリーズ： 子どもの心の診療シリーズ
電子書籍版： 2010-09-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,290 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

4,290 円(税込)

購入する

商品紹介

本書では、子どものうつ病性障害、不安障害、および発達障害、それぞれの併存を考慮しつつ、不登校やひきもこり、自傷や自殺等、現在の子どもが抱える心の問題への対応と治療の実際について詳述した。

目次

  • 子どもの心の診療シリーズ　4　子どもの不安障害と抑うつ

    ―目次―

    I. 子どもの不安と抑うつをどうとらえるか
    　１.臨床的立場から
    　２.生物学的立場から

    II.子どもの不安障害とその周辺
    　１.パニック障害
    　２.強迫性障害
    　３.選択緘黙（場面緘黙）
    　４.社会恐怖（社会不安障害）
    　５.全般性不安障害
    　６.分離不安障害
    　７.解離性障害
    　８.広汎性発達障害と不安障害
    　９.ADHDと不安障害
    　10.青年期の不安障害の生物学的知見
    　11.不安障害の薬物療法
    　12.不安障害に対する行動療法

    III.子どもの抑うつとその周辺
    　１.大うつ病性障害
    　２.（大）うつ病の薬物療法
    　３.抑うつの疫学
    　４.広汎性発達障害と気分障害
    　５.ADHDと抑うつ
    　６.大うつ病の生物学的知見
    　７.自傷と自殺
    　８.広汎性発達障害と自殺
    　９.自殺の生物学的知見

    IV.関連する領域
    　１.不登校
    　２.ひきこもり
    　３.不安障害・抑うつと心理療法
    　４.双極性障害

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 子どもの不安と抑うつをどうとらえるか

P.11 掲載の参考文献
1) Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999;22:517-534.
PubMed
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR). Washington DC:American Psychiatric Association;2000.
 
3) Biederman J, et al. Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 1991;48:633-642.
PubMed
4) 傳田健三. 抑うつ状態を伴うpanic disorderの臨床的研究. 精神医学1996;38(7):709-717.
 
5) 傳田健三ほか. 児童・青年期の気分障害に関する臨床的研究. 児童青年精神医学とその近接領域2001;42:277-302.
 
6) 傳田健三. 小児のうつと不安-診断と治療の最前線. 東京:新興医学出版社;2006.
 
7) 傳田健三. 子どものうつ病-発達障害とbipolarityの視点から. 精神科治療学2008;23(7):813-822.
 
8) Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999:The prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 2003;42:1203-1211.
PubMed
9) Geller B, et al. Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect Disord 1998;51:81-91.
 
10) Ghaemi SN, Ko JY, Goodwin FK. The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract 2001;7:287-297.
 
11) Harrington R. Affective disorders. In:Rutter M, Taylor E(eds). Child and Adolescent Psychiatry:Modern Approaches, 4th edition, Chapter 29. Oxford:Blackwell Science;2002. pp463-485/長尾圭造, 宮本信也(監訳). 児童精神医学. 東京:明石書店;2007.
 
12) 井上猛, 田中輝明, 鈴木克治.治療困難な病態-双極性うつ病. こころの科学2007;131:72-76.
 
P.21 掲載の参考文献
1) Axelson DA, Birmaher B. Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety 2001;14(2):67-78.
PubMed
2) Balleine BW, Killcross S. Parallel incentive processing:An integrated view of amygdala function. Trends Neurosci 2006;29(5):272-279.
PubMed
3) Bishop SJ. Neurocognitive mechanisms of anxiety:An integrative account. Trends Cogn Sci 2007;11(7):307-316.
PubMed
4) Boes AD, et al. Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children. Biol Psychiatry 2008;63(4):391-397.
PubMed
5) Dahlstrom M, et al. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. Mol Psychiatry 2000;5(5):514-522.
PubMed
6) Eichenbaum H, et al. The medial temporal lobe and recognition memory. Annu Rev Neurosci 2007;30:123-152.
PubMed
7) Emslie GJ, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54(11):1031-1037.
PubMed
8) Forbes EE, et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 2009;166(1):64-73.
PubMed
9) Fusar-Poli P, et al. Functional atlas of emotional faces processing:A voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci 2009;34(6):418-432.
PubMed
10) Giedd JN. The teen brain:Insights from neuroimaging. J Adolesc Health 2008;42:335-343.
PubMed
11) Gomez L, et al. G72/G30(DAOA) and juvenile-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 2009;150B(7):1007-1012.
PubMed
12) Hankin BL, et al. Development of depression from preadolescence to young adulthood:Emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol 1998;107(1):128-140.
 
13) Harmer CJ, et al. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59(9):816-820.
PubMed
14) Hazell P, et al. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002 (;2):CD002317.
 
15) Herman JP, et al. Central mechanisms of stress integration:Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003;24(3):151-180.
PubMed
16) Herman JP, et al. Limbic system mechanisms of stress regulation:Hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005;29(8):1201-1213.
PubMed
17) Hetrick SE, et al. Selective serotonin reuptake inhibitors(SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007 (;3):CD004851.
 
18) Kanner AM. Is major depression a neurologic disorder with psychiatric symptoms? Epilepsy Behav 2004;5(5):636-644.
PubMed
19) Killgore WDS, Yurgelun-Todd DA. Ventromedial prefrontal activity correlates with depressed mood in adolescent children. Neuroreport 2006;17(2):167-171.
PubMed
20) Koenigs M, Grafman J. The functional neuroanatomy of depression:Distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009;201(2):239-243.
PubMed
21) Lucassen PJ, et al. Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 2006;5(5):531-546.
PubMed
22) Lyoo K, et al. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr Psychiatry 2002;43(5):361-368.
 
23) MacMaster FP, Kusumakar V. MRI study of the pituitary gland in adolescent depression. J Psychiatr Res 2004;38(3):231-236.
PubMed
24) MacMillan S, et al. Increased amygdala:Hippocampal volume ratios associated with severity of anxiety in pediatric major depression. J Child Adolesc Psychopharmacol 2003;13(1):65-73.
PubMed
25) Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007;10(9):1089-1093.
PubMed
26) Masi G, Liboni F, Brovedani P. Pharmacotherapy of major depressive disorder in adolescents. Expert Opin Pharmacother 2010;11(3):375-386.
PubMed
27) Oh JE, et al. Paradoxical anxiogenic response of juvenile mice to fluoxetine. Neuropsychopharmacology 2009;34(10):2197-2207.
PubMed
28) Pauli-Pott U, et al. Serotonin transporter gene polymorphism(5-HTTLPR), environmental conditions, and developing negative emotionality and fear in early childhood. J Neural Transm 2009;116(4):503-512.
PubMed
29) Pine DS. Research review:A neuroscience framework for pediatric anxiety disorders. J Child Psychol Psychiatry 2007;48(7):631-648.
PubMed
30) Pompili M, et al. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur Arch Psychiatry Clin Neurosci 2007;257(8):494-499.
PubMed
31) Pretorius E. Corticosteroids, depression and the role of serotonin. Rev Neurosci 2004;15(2):109-116.
PubMed
32) Reinblatt SP, Riddle MA. The pharmacological management of childhood anxiety disorders:A review. Psychopharmacology 2007;191(1):67-86.
PubMed
33) Rice F. The genetics of depression in childhood and adolescence. Curr Psychiatry Rep 2009;11 (2):167-173.
PubMed
34) Ridderinkhof KR, et al. Neurocognitive mechanisms of cognitive control:The role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn 2004;56(2):129-140.
PubMed
35) Rodrigues SM, LeDoux JE, Sapolsky RM. The influence of stress hormones on fear circuitry. Annu Rev Neurosci 2009;32:289-313.
PubMed
36) Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat Rev Neurosci 2009;10(6):423-433.
PubMed
37) Rosso IM, et al. Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry 2005;57(1):21-26.
PubMed
38) Schunke M, Schulte E, Schumacher U. Prometheus LernAtlas der Anatomie. Stuttgart:Georg Thieme Verlag;2006/坂井建雄, 河田光博(監訳). プロメテウス 解剖学アトラス-頭部/神経解剖. 東京:医学書院;2009.
 
39) Shaw P. Intelligence and the developing human brain. Bioessays 2007;29:962-973.
PubMed
40) Simons JS, Spiers HJ. Prefrontal and medial temporal lobe interactions in long-term memory. Nat Rev Neurosci 2003;4(8):637-648.
PubMed
41) Sotres-Bayon F, Cain CK, LeDoux JE. Brain mechanisms of fear extinction:Historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry 2006;60(4):329-336.
PubMed
42) Steingard RJ, et al. Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry 1996;35(3):307-311.
 
43) Talge NM, Neal C, Glover V. Antenatal maternal stress and long-term effects on child neurodevelopment:How and why? J Child Psychol Psychiatry 2007;48(3-4):245-261.
 
44) Thomas KM, et al. Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 2001;58(11):1057-1063.
PubMed
45) Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009;10(6):397-409.
PubMed
46) van Strien NM, Cappaert NLM, Witter MP. The anatomy of memory:An interactive overview of the parahippocampal-hippocampal network. Nat Rev Neurosci 2009;10(4):272-282.
PubMed
47) Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006;31(6):1097-1111.
PubMed
48) Weinstock M. The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev 2008;32(6):1073-1086.
 
49) Whittington CJ, et al. Selective serotonin reuptake inhibitors in childhood depression:Systematic review of published versus unpublished data. Lancet 2004;363(9418):1341-1345.
PubMed
50) Yildiz-Yesiloglu A, Ankerst DP. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder:A meta-analysis. Psychiatry Res 2006;147(1):1-25.
PubMed

II. 子どもの不安障害とその周辺

P.33 掲載の参考文献
1) American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Test Revision. Washington DC:American Psychiatric Association;2000.
 
2) Ballenger JC, et al. Three cases of panic disorder with agoraphobia in children. Am J Psychiatry 1989;146:922-924.
PubMed
3) Bernstein GA, Borchardt CM. Anxiety disorders of childhood and adolescence:A critical review. J Am Acad Child Adolesc Psychiatry 1991;30:519-532.
PubMed
4) Bernstein GA, Borchardt CM, Perwien AR. Anxiety disorders in children and adolescents:A review of past 10 years. J Am Acad Child Adolesc Psychiatry 1996;35:1110-1119.
PubMed
5) Biederman J. Clonazepam in the treatment of prepubertal children with panic-like symptoms. J Clin Psychiatry 1987;48:38-41.
PubMed
6) Biederman J, et al. Panic disorder and agoraphobia in consecutively referred children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:214-223.
PubMed
7) Black B, Robbins DR. Panic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1990;29:36-44.
PubMed
8) Chambers WJ, et al. The assessment of affective disorders in children and adolescents by semistructured interview:Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry 1985;42:696-702.
PubMed
9) Clark DB, Donovan JE. Reliability and validity of the Hamilton Anxiety Rating Scale in an adolescents sample. J Am Acad Child Adolesc Psychiatry 1994;33:354-360.
 
10) Crowe RR. Mitral valve prolapse and panic disorder. Psychiatr Clin North Am 1985;8:63-71.
PubMed
11) Fairbanks JM, et al. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 1997;7:17-29.
PubMed
12) Hayward C, et al. Pubertal stage and panic attack history in sixth- and seventh-grade girls. Am J Psychiatry 1992;149:1239-1243.
PubMed
13) Herman SP, Sticker GP, Lucas AR. Hyperventilation syndrome in children and adolescents:Long term follow-up. Pediatrics 1981;67:183-187.
 
14) Keeley ML, Storch EA. Anxiety disorders in youth. J Pediatr Nurs 2008;24(1):26-40.
PubMed
15) Klein D. Delineation of two-drug responsive anxiety syndromes. Psychopharmacologia 1964;5:397-408.
PubMed
16) Klein DF. Anxiety reconceptualized. In:Klein DF, Rabkin J(eds). Anxiety:New Research and Changing Concepts. New York:Raven Press;1981. pp235-263.
 
17) Klein DF. Psychopharmacologic treatment of panic disorder. Psychosomatics 1984;25(10):32-36.
 
18) Last CG, Strauss CC. Panic disorders in children and adolescents. J Anx Disord 1989;3:87-95.
 
19) Last CG, et al. A prospective study of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1996;35:1502-1510.
PubMed
20) Macauley JL, Kleinknecht RA. Panic and panic attacks in adolescents:A review. J Anx Disord 1989;3:221-241.
 
21) Masi G, et al. Panic disorder in clinically referred children and adolescents. Child Psychiatry Hum Dev 2000;31:139-151.
PubMed
22) Moreau DL, Weissman L, Warner V. Panic disorder in children at high risk for depression. Am J Psychiatry 1989;146:1059-1060.
 
23) Nauta MH, et al. Cognitive-behavioral therapy for children with anxiety disorders in a clinical setting:No additional effect of a cognitive parent training. J Am Acad Child Psychiatry 2003;42(11):1270-1278.
 
24) Nelles WB, Barlow DH. Do children panic? Clin Psychol Rev 1988;8:359-372.
 
25) Norton GR, Dorward J, Cox BJ. Factor associated with panic attacks in nonclinical subjects. Behav Ther 1986;17:239-252.
 
26) Pollack MH, et al. Relationship of childhood anxiety to adult panic disorder:Correlates and influence on course. Am J Psychiatry 1996;153:376-381.
PubMed
27) Renaud J, et al. Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder:A pilot study. J Child Adolesc Psychopharmacol 1999;9:73-83.
PubMed
28) Vitiello B, Behar D, Wolfson S, et al. Diagnosis of panic disorder in pretubertal children. J Am Acad Child Adolesc Psychiatry 1990;29:782-784.
 
29) Von Korff M, Eaton W, Keyl P. The epidemiology of panic attacks and panic disorders:Results of three community surveys. Am J Epidemiol 1985;122:970-981.
PubMed
30) Weissman M. The epidemiology of panic disorder in adolescents:Implication for diagnosis. In:Proceedings of Annual Meeting American Academy of Child and Adolescent Psychiatry. San Francisco:Am Acad Child Adolesc Psychiatry;1989.
 
31) Welner Z, et al. Reliability, validity and parent-child agreement of the Diagnostic Interview for Children and Adolescents(DICA). J Am Acad Child Adolesc Psychiatry 1987;26:649-653.
PubMed
P.45 掲載の参考文献
1) American Psychiatric Association. DSM-IV-TR精神疾患の分類と診断の手引き. 東京:医学書院;2003.
 
2) Boxter LR, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder:A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211-218.
 
3) Castle DJ, Deale A, Marks IM. Gender differences in obsessive compulsive disorder. Aust N Z J Psychiatry 1995;29(1):114-117.
PubMed
4) Fireman B, et al. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry 2001;158(11):1904-1910.
 
5) Flament MF, et al. Obsessive-compulsive disorder in adolescence:An epidemiological study. J Am Acad Child Adolesc Psychiatry 1988;27:764-771.
PubMed
6) Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006;29(2):353-370.
PubMed
7) 石坂好樹. 児童・青年期の強迫神経症. 精神科治療学1990;5(11):1369-1377.
 
8) Karno M, Golding J. Obsessive-compulsive disorder. In:Psychiatric Disorders in America:The Epidemiologic Catchment Area Study. New York:The Free Press;1990. pp204-219.
 
9) Leonard HL, et al. Tics and Tourette's disorder:A 2-to 7-year follow-up of 54 obsessivecompulsive children. Am J Psychiatry 1992;149(9):1244-1251.
PubMed
10) Mancebo MC, et al. Juvenile-onset OCD:Clinical features in children, adolescents and adults. Acta Psychiatr Scand 2008;118(2):149-159.
PubMed
11) Pauls DL, et al. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152(1):76-84.
PubMed
12) Pediatric OCD Treatment Study(POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder:The Pediatric OCD Treatment Study(POTS) randomized controlled trial. JAMA 2004;292(16):1969-1976.
PubMed
13) Rettew D, et al. Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992;31(6):1050-1056.
PubMed
14) Robins L, et al. The NIMH Epidemiological Catchment Area study. Arch Gen Psychiatry 1981;38:381-389.
 
15) Scahill L, et al. Children Yale-Brown Obsessive Compulsive Scale:Reliability and validity. J Am Acad Psychiatry 1997;36(6):844-852.
PubMed
16) Stewart SE, et al. Long-term outcome of pediatric obsessive-compulsive disorder:A metaanalysis and qualitative review of the literature. Acta Psychiatr Scand 2004;110(1):4-13.
PubMed
17) Storch EA, et al. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder:Comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007;46(4):469-478.
PubMed
18) Storch EA, et al. Insight in pediatric obsessive-compulsive disorder:Associations with clinical presentation. Psychiatry Res 2008;160(2):212-220.
PubMed
19) Swedo SE, et al. Obsessive-compulsive disorder in children and adolescents:Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989;46(4):335-341.
PubMed
20) 多賀千明. 強迫性障害-評価尺度としてのY-BOCSとNIMH global scale. 臨床精神薬理 1999;2(11):1235-1243.
 
21) Tumkaya S, et al. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight:A neuropsychological comparison. Psychiatry Res 2009;165(1-2):38-46.
 
22) Wewetzer C, et al. Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescense. Eur Child Adolesc Psychiatry 2001;10:37-46.
 
P.55 掲載の参考文献
1) Bishop BVM. Developmental disorders of speech and language. In:Rutter M, et al(eds). Child and Adolescent Psychiatry, 3rd edition. Oxford:Blackwell Scientific Publications;1994. pp556-557.
 
2) Cohan SL, Chavira DA, Stein MB. Practitioner review:Psychosocial interventions for children with selective mutism:A critical evaluation of the literature from 1990-2005. J Child Psychol Psychiatry 2006;47(11):1085-1097.
PubMed
3) Dummit ES, et al. Systematic assessment of 50 children with selective mutism. J Am Acad Child Adolesc Psychiatry 1997;36(5):653-660
 
4) Kristensen H. Selective mutism and comorbidity with developmental disorder/delay, anxiety disorder, and elimination disorder. J Am Acad Child Adolesc Psychiatry 2000;39:249-256.
PubMed
5) 大井正己ほか. 児童期の選択緘黙についての一考察. 精神経誌 1979;81(6):365-389.
 
6) 大井正己. 選択緘黙. 中根晃(編). 子どもと思春期の精神医学. 東京:金剛出版;2008. pp520-525.
 
7) 大村豊. 選択緘黙-成人期への影響. 精神科治療学 2006;21(3):249-256.
 
8) Sadock BJ, Sadock VA. Kaplan & Sadock's Synopsis of Psychiatry:Behavioral Sciences/Clinical Psychiatry, 9th edition. Philadelphia:Lippincott Williams & Wilkins;2003/井上令一, 四宮慈子(監訳). カプラン臨床精神医学テキスト. 東京:メディカル・サイエンス・インターナショナル;2004.
 
9) Sluckin A, Foreman N, Herbert M. Behavioral treatment programs and selectivity of speaking at follow-up in a sample of 25 selective mules. Austr Psychologist 1991;26:132-137.
 
10) Steinhausen HC, et al. A long-term outcome study of selective mutism in childhood. J Child Psychol Psychiatry 2006;47:751-756.
PubMed
11) 渡部泰弘, 榊田理恵. 自閉症スペクトラムの観点から検討した選択性緘黙の4例. 児精医誌 2009;50(5):491-503.
Medical*Online
12) WHO. The ICD-10 Classification of Mental and Behavioural Disorders:Clinical Descriptions and Diagnostic Guidelines. Geneva:WHO;1993/融道男ほか(監訳). ICD-10精神および行動の障害-臨床記述と診断ガイドライン. 東京:医学書院;2005.
 
13) WHO. The ICD-10 Classification of Mental and Behavioural Disorders:Diagnostic Criteria for Research. Geneva:WHO;1993/中根允文ほか(訳). ICD-10 精神および行動の障害-DCR研究用診断基準. 東京:医学書院;1994.
 
14) Yeganeh R, et al. Clinical disorders between selective mutism and social phobia:An investigation of childhood psychopathology. J Am Acad Child Adolesc Psychiatry 2005;42:1069-1075.
 
P.67 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. Washington DC:APA;1980.
PubMed
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, Revised. Washington DC:APA;1987.
 
3) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington DC:APA;1994.
 
4) 朝倉聡ほか. Liebowitz Social Anxiety Scale(LSAS)日本語版の信頼性および妥当性の検討. 精神医学 2002;44:1077-1084.
 
5) Asakura S, Tajima O, Koyama T. Fluvoxamine treatment of generalized social anxiety disorder in Japan:A randomized double-blind, placebo-controlled study. Int J Neuropsychopharmacol 2007;10:263-274.
PubMed
6) 朝倉聡, 小山司, 筒井末春. Paroxetine塩酸塩水和物の社会不安障害に対する臨床評価-プラセボを対照とした二重盲検比較試験. 臨床精神医学 2008;37:833-848.
Medical*Online
7) Bartz JA, Hollander E. The neuroscience of affiliation:Forging links between basic and clinical research on neuropeptides and social behavior. Horm Behav 2006;50:518-528.
PubMed
8) Chavira DA, et al. Child anxiety in primary care:Prevalent but untreated. Depress Anxiety 2004;20:155-164.
PubMed
9) Clark DM, Wells A. A cognitive model of social phobia. In:Heimberg RG, et al(eds). Social Phobia:Diagnosis, Assessment and Treatment. New York:Guilford Press;1995. pp69-93.
 
10) Clark DM, et al. Cognitive therapy versus exposure and applied relaxation in social phobia:A randomized controlled trial. J Consult Clin Psychol 2006;74:568-578.
PubMed
11) Davidson JRT, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428.
 
12) Etkin A, Wager TD. Functional neuroimaging of anxiety:A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007;164:1476-1488.
PubMed
13) Furmark T, et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 2002;59:425-433.
PubMed
14) Gelernter CS, et al. Cognitive-behavioural and pharmacological treatments of social phobia:A cotrolled study. Arch Gen Psychiatry 1991;48:938-945.
 
15) Gelernter J, et al. Genome-wide linkage scan for loci predisposing to social phobia:Evidence for a chromosome 16 risk locus. Am J Psychiatry 2004;161:59-66.
PubMed
16) Herbert JD, Hope DA, Bellack AS. Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol 1992;101:332-339.
PubMed
17) Huppert JD, Roth DA, Foa EB. Cognitive-behavioral treatment of social phobia:New advances. Curr Psychiatry Rep 2003;5:289-296.
PubMed
18) 笠原敏彦. 対人恐怖と社会恐怖(ICD-10)の診断について. 精神経誌 1995;97:357-366.
 
19) 笠原嘉ほか. 正視恐怖・体臭恐怖-主として精神分裂病との境界例について. 東京:医学書院;1972.
 
20) 笠原嘉. 対人恐怖. 加藤正明ほか(編). 新版 精神医学事典. 東京:弘文堂;1993. p515.
 
21) Kasper S, et al. Escitalopram in the treatment of social anxiety disorder:Randomized, doubleblind, placebo-controlled, flexible-dosege study. Br J Psychiatry 2005;186:222-226.
 
22) Katzelnick DJ, et al. Sertraline for social phobia:A double-blind, placebo-controlled crossover study. Am J Psychiatry 1995;152:1368-1371.
PubMed
23) 川上憲人. こころの健康についての疫学調査に関する研究. 平成16～18年度厚生労働科学研究費補助金(こころの健康科学事業)「心の健康についての疫学調査に関する研究」総合研究報告書. 2007. pp1-21.
 
24) Kessler RC, et al. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
PubMed
25) Kessler RC, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627.
PubMed
26) Kirsch P, et al. Oxytocine modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005;25:11489-11493.
PubMed
27) Lader M, et al. Efficacy and tolerability of escitalopram in 12-and 24-week treatment of social anxiety disorder:Randomized, double-blind, placebo-controlled, fixed-dose study. Depress Anxiety 2004;19:241-248.
 
28) Liebowitz MR, et al. Phenelzine versus atenolol in social phobia:A placebo-controlled comparison. Arch Gen Psychiatry 1992;49:290-300.
 
29) Liebowitz MR, et al. A randomized, double-blind, fixed-dosed comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. J Clin Psychiatry 2002;63:66-74.
 
30) Liebowitz MR, et al. Efficacy of sertraline in sever generalized social anxiety disorder:Results of a double-blind, placebo-controlled study. J Clin Psychiatry 2003;64:785-792.
PubMed
31) Liebowitz MR, Gelenberg AJ, Munjack D. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry 2005;62:190-198.
PubMed
32) Liebowitz MR, et al. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry 2005;66:238-247.
PubMed
33) Montgomery SA, et al. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. J Clin Psychiatry 2005;66:1270-1278.
PubMed
34) Mortberg E, et al. Intensive group cognitive treatment and individual cognitive therapy vs treatment as usual in social phobia:A randomized controlled trial. Acta Psychiatr Scand 2007;115:142-154.
PubMed
35) 日本精神神経学会・精神科用語検討委員会(編). 精神神経学用語集, 改訂6版. 東京:新興医学出版社;2008.
 
36) Rickeles K, Mangano R, Khan A. A double-blind, placebo-controlled, study of a flexible dose of venlafaxine ER in adult outpatients with in generalized social anxiety disorder. J Clin Psychopharmacol 2004;24:488-496.
 
37) Schneier FR, et al. Social phobia:Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992;49:282-288.
 
38) Schneier FR, et al. Low dopamine D2 receptor binding potential in social phobia. Am J Psychiatry 2000;157:457-459.
PubMed
39) Stein DJ, et al. Predictors of response to pharmacotherapy in social anxiety disorder:An analysis of 3 placebo-controlled paroxetine trials. J Clin Psychiatry 2002;63:152-155.
PubMed
40) Stein DJ, et al. Efficacy of paroxetine for relapse prevention in social anxiety disorder:A 24-week study. Arch Gen Psychiatry 2002;59:1111-1118.
PubMed
41) Stein MB, et al. A direct-interview family study of generalized social phobia. Am J Psychiatry 1998;155:90-97.
PubMed
42) Stein MB, et al. Paroxetine in the treatment of generalized social phobia(social anxiety disorder). JAMA 1998;280:708-713.
PubMed
43) Stein MB, et al. Fluvoxamine in the treatment of social phobia:A double-blind, placebocontrolled study. Am J Psychiatry 1999;156:756-760.
PubMed
44) Stein MB, Jang KL, Livesley WJ. Heritability of social-anxiety related concerns and personality characteristics:A twin study. J Nerv Ment Dis 2002;190:219-224.
PubMed
45) Stein MB, et al. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder:6-month randomized controlled trial. Psychopharmacology(Berl) 2005;177:280-288.
PubMed
46) 立森久照. こころの健康についての疫学調査(世界精神保健日本調査)の主要結果. 平成16～18年度厚生労働科学研究費補助金(こころの健康科学事業)「心の健康についての疫学調査に関する研究」総合研究報告書. 2007. pp35-75.
 
47) The Research Unit on Pediatric Psychopharmacolgy Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001;344:1279-1285.
 
48) Tiihonen J, et al. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997;154:239-242.
PubMed
49) 植元行男ほか. 思春期における異常な確信体験について(そのI)-いわゆる思春期妄想症について. 児精誌 1967;8:155-167.
 
50) van Ameringen MA, et al. Sertraline treatment of generalized social phobia:A 20-week, double-blind, placebo-controlled study. Am J Psychiatry 2001;158:275-281.
PubMed
51) van der Linden GJ, Stein DJ, van Balkom AJ. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder(social phobia):A meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 2000;15(Suppl 2):S15-24.
 
52) van Vliet IM, den Boer JA, Westenberg HGM. Psychopharmacological treatment of social phobia:A double-blind placebo controlled study with fluvoxamine. Psychopharmacology 1994;115:128-134.
 
53) Wagner KD, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry 2004;61:1153-1162.
PubMed
54) Walker JR, et al. Prevention of relapse in generalized social phobia:Results of a 24-week study in response to 20 weeks of sertraline treatment. J Clin Psychopharmacol 2000;20:636-644.
 
55) 山下格. 対人恐怖. 東京:金原出版;1977.
 
56) 山下格. 対人恐怖の病理と治療, 精神科治療学1997;12:9-13.
 
P.79 掲載の参考文献
1) Akiskal HS. Toward a definition of generalized anxiety disorder as an anxious temperament type. Acta Psychiatr Scand 1998;98(Suppl 393):66-73.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition(DSM-IV). Washington DC:American Psychiatric Association;1994.
 
3) Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand 1991;84:446-452.
PubMed
4) Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents:Developmental issues and implications for DSM-V. Psychiatr Clin N Am 2009;32(3):483-524.
 
5) Bridget K, et al. Determinants of somatization in primary care. Psychol Med 1991;21:473-483.
 
6) Carballo JJ, et al. Stability of childhood anxiety disorder diagnoses:A follow-up naturalistic study in psychiatric care. Eur Child Adolesc Psychiatry 2010;19:395-403.
 
7) De Bellis MD, et al. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry 2000;48(1):51-57.
PubMed
8) DeBeurs E, et al. Predictors of change in anxiety symptoms of older persons:Results from the longitudinal aging study Amsterdam. Psychol Med 2000;30(3):515-527.
 
9) Dugas MJ, et al. Generalized anxiety disorder:A preliminary test of a conceptual model. Behav Res Ther 1998;36(2):215-226.
PubMed
10) Kagan J, Reznick JS, Snidman N. Biological bases of childhood shyness. Science 1998;240:161-171.
 
11) Kendler KS, et al. Childhood parental loss and adult psychopathology in women:A twin study perspective. Arch Gen Psychiatry 1992;49(2):109-116.
PubMed
12) Kendler KS, et al. Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 2003;60 (8):789-796.
PubMed
13) Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):593-602.
PubMed
14) Klein RG,Pine DS. Anxiety disorder. In:Rutter M, et al(eds).Child and Adolescent Psychiatry, 4th edition. Oxford:Blackwell Publishing;2002/日本小児精神医学研究会(訳). 不安障害. 長尾圭造, 宮本信也(監訳). 児童青年精神医学. 東京:明石書店;2007. pp567-591.
 
15) McCathie H, Spence SH. What is the revised fear survey schedule for children measuring? Behav Res Ther 1991;29(5):495-502.
PubMed
16) McClure EB, et al. Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry 2007;64(1):97-106.
PubMed
17) Moffitt TE, et al. Generalized anxiety disorder and depression:Childhood risk factors in a birth cohort followed to age 32. Psychol Med 2007;37:441-452.
 
18) Muris P, et al. Common fears and their relationship to anxiety disorders symptomatology in normal children. Pers Individ Dif 1998;24(4):575-578.
 
19) 野上芳美. 浮動性不安. 加藤正明ほか(編). 新版 精神医学事典. 東京:弘文堂;1992. pp702-703.
 
20) Pine DS, et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disordrs. Arch Gen Psychiatry 1998;55(1):56-64.
 
21) Rickels K, et al. Antidepressants for the treatment of generalized anxiety disorder:A placebocontrolled comparison of imiplamine, trazodone, and diazepam. Arch Gen Psychiatry 1993;50 (11):884-895.
PubMed
22) Rickels K, Rynn M. Overview and clinical presentation of generalized anxiety disorder. Psychiatr Clin N Am 2001;24(1):1-17.
 
23) RUPP Anxiety Study Group. Fluvoxamine treatment of anxiety disorders in children and adolescents. N Engl J Med 2001;344:1279-1285.
 
24) Sadock BJ, Sadock VA. Kapran & Sadock's Synopsis of Psychiatry:Behavioral Science / Clinical, 9th edition. Philadelphia:Lippincott Williams & Wilkins;2003.
 
25) Smoller JW, et al. Association of genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry 2003;54(12):1376-1381.
PubMed
26) WHO. The ICD-10 Classification of Mental and Behavioural Disorders:Diagnostic Criteria for Research. Geneva:WHO;1993.
PubMed
27) Wittchen HU, et al. The waxing and waning of mental disorders:Evaluating the stability of syndromes of mental disorders in the population. Compr Psychiatry 2000;41(2 Suppl 1):122-132.
 
P.89 掲載の参考文献
1) Bowlby J(黒田実郎<訳>). 母子関係の理論II 分離不安. 東京:岩崎学術出版社;1977.
 
2) 神尾陽子, 上手幸治. 子どもの愛着行動にみられるさまざまな病理. 中根晃ほか(編). 詳細 子どもと思春期の精神医学. 東京:金剛出版;2008. pp513-519.
 
3) 久保田まり. 愛着研究はどのように進んできたか. そだちの科学 2006;7:2-10.
 
4) Schore AN. Effects of a secure attachment relationship on right brain development, affect regulation, and infant mental health. Infant Ment Health J 2001;22:7-66.
 
P.97 掲載の参考文献
1) American Psychiatric Association. Quick Reference to the Diagnostic Criteria from DSM-IV-TR. Washington DC:APA;2000/高橋三郎, 大野裕, 染矢俊幸(訳). DSM-IV-TR 精神疾患の分類と診断の手引き. 東京:医学書院;2002.
 
2) Armstrong JG, et al. Development and validation of a measure of adolescent dissociation:The Adolescent Dissociative Experiences Scale. J Nerv Ment Dis 1997;185(8):491-497.
PubMed
3) Becker-Blease KA, et al. A genetic analysis of individual differences in dissociative behaviors in childhood and adolescence. J Child Psychol Psychiatry 2004;45(3):522-532.
PubMed
4) Brown RJ, et al. Should conversion disorder be reclassified as a dissociative disorder in DSM V? Psychosomatics 2007;48(5):369-378.
PubMed
5) 河村雄一ほか. 児童期に解離症状がみられた18例の臨床的研究. 児童青年精神医学とその近接領域 2000;41(5):505-513.
 
6) Murase S, et al. Polysymptomatic conversion disorder in childhood and adolescence in Japan:Early manifestation or incomplete form of somatization disorder? Psychother Psychosom 2000;69(3):132-136.
PubMed
7) 村瀬聡美. 児童期の解離. 児童青年精神医学とその近接領域2005;46(5):508-511.
 
8) 村瀬聡美. 転換性障害・解離性障害. 本城秀次(編). よくわかる精神保健. 京都:ミネルヴァ書房;2009. pp96-97.
 
9) 村瀬聡美. 子どもの解離傾向と精神医学的諸問題. 本城秀次(監). 子どもの発達と情緒の障害-事例からみる現代児童精神医学の臨床. 東京:岩崎学術出版社. 印刷中.
 
10) Putnum FW. Dissociation in Children and Adolescents:A Developmental Perspective. New York:Guilford Press;1997/中井久夫(訳). 解離-若年期における病理と治療. 東京:みすず書房, 2001.
 
11) Shapiro F. Eye Movement Desensitization and Reprocessing:Basic Principles, Protocols, and Procedures, 2nd edition. New York:Guilford Press;2001/市井雅哉(監訳). EMDR-外傷記憶を処理する心理療法. 大阪:二瓶社;2004.
 
12) 田辺肇. 日本版A-DES(Adolescent Dissociative Experiences Scale;思春期・青年期解離性体験尺度)の作成. 第48回日本催眠学会抄録集. 2002. p25.
 
13) Yoshizumi T, et al. Psychometric properties of the Adolescent Dissociative Experiences Scale (A-DES) in Japanese adolescents from a community sample. J Trauma Dissoc in press.
 
P.107 掲載の参考文献
1) American Academy of Child and Adolescent Psychiatry. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1999;38(12):1611-1616.
PubMed
2) Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285:3093-3099.
PubMed
3) Farrugia S, Hudson J. Anxiety in adolescents with Asperger syndrome:Negative thoughts, behavioral problems, and life interference. Focus Autism Other Dev Disabil 2006;21:25-35.
 
4) Ghaziuddin M, Weidmer-Mikhail E, Ghaziuddin N. Comorbidity of Asperger syndrome:A preliminary report. J Intellect Disabil Res 1998;42:279-283.
PubMed
5) Green J, et al. Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. J Autism Dev Disord 2000;30:279-293.
PubMed
6) Kim JA, et al. The prevalence of anxiety and mood problems among children with autism and Asperger syndrome. Autism Int J Res Pract 2000;14:117-132.
 
7) Larsen FW, Mouridsen SE. The outcome in children with childhood autism and Asperger syndrome originally diagnosed as psychotic:A 30-year follow-up study of subjects hospitalized as children. Eur Child Adolesc Psychiatry 1997;6:181-190.
PubMed
8) Leyfer OT, et al. Comorbid psychiatric disorders in children with autism:Interview developmental and rates of disorders. J Autism Dev Disord 2006;36:849-861.
 
9) Matson JL, Love SR. A comparison of parent-reportted fear for autistic and non-handicapped age-matched children and youth. Aust N Z J Dev Disabil 1990;16:349-357.
 
10) Matson JL, Nebel-Schwalm MS. Comorbid psychopathology with autism spectrum disorder in children:An overview. Res Dev Disabil 2007;28(4):341-352.
PubMed
11) Muris P, et al. Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord 1998;12:387-393.
PubMed
12) 崎濱盛三ほか. 広汎性発達障害と側頭葉てんかんにおける強迫症状の合併とその特徴. 第48回日本児童青年精神医学会総会(口頭発表). 盛岡. 2008.
 
13) Shtayermman O. Peer victimization in adolescents and young adults diagnosed with Asperger's syndrome:A link to depressive symptomatology, anxiety symptomatology and suicidal ideation. Issues Compr Pediatr Nurs 2007;30:87-107.
 
14) Szatmari P, et al. A follow-up study of high-functioning autistic children. J Autism Dev Disord 1989;19:213-225.
 
15) Tantam D. Asperger syndrome in adulthood. In:Frith U(ed). Autism and Asperger Syndrome. Cambridge:Cambridge Univ Press;1991. pp147-183.
 
16) 十一元三. 広汎性発達障害における強迫関連現象. 児童青年精神医学とその近接領域 2006;47:127-134.
Medical*Online
P.114 掲載の参考文献
1) Biederman J. Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry 1991;148:251-256.
PubMed
2) Bowen R, et al. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008;157:201-209.
PubMed
3) Christopher J, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry 2005;44:915-924.
 
4) Geller DA, et al. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive compulsive disorder:Fact or artifact? J Am Acad Child Adolesc Psychiatry 2002;41:52-58.
PubMed
5) Gershon J. A meta-analytic review of gender differences in ADHD. J Atten Disord 2002;5:143-154
 
6) Jensen PS, et al. ADHD comorbidity findings from the MTA study:Comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40:147-158.
PubMed
7) Manassis K, Tannock R, Barbosa J. Dichotic listening and response inhibition in children with comorbid anxiety disorders in ADHD. J Am Acad Child Adolesc Psychiatry 2000;39(9):1152-1159.
PubMed
8) Masi G, et al. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Compr Psychiatry 2006;47:42-47.
PubMed
9) Moll GH, et al. A quantitative and qualitative aspects of obsessive-compulsive behaviour in children with attention deficit hyperactivity disorder. Acta Psychiatr Scand 2000;101:389-394.
PubMed
10) Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 1989;28:882-887.
PubMed
11) Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder:An overview. J Clin Psychiatry 1998;59:50-58.
PubMed
12) Pliszka SR, Carlson C, Swanson JM. ADHD with comorbid disorders. In:Pliszka SR. Clinical Assessment and Management. New York:Guilford;1999. pp17-48.
 
13) Roth RM, et al. Contribution of organizational strategy to verbal learning and memory in adults with attention-deficit/hyperactivity disorder. Neuropsychology 2004;18:78-85.
PubMed
14) Safren SA. Prevalence of childhood ADHD among patients with generalized anxiety disorder and a comparison condition, social phobia. Depress Anxiety 2001;13:190-191.
 
15) 齊藤万比古ほか. 注意欠陥/多動性障害(ADHD)の診断および治療に関する調査. 厚生労働省「精神神経疾患研究委託費」14-指8 注意欠陥/多動性障害の総合的評価と臨床的実証研究報告書. 2000. pp15-37.
 
16) Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry 2006;67:27-31.
PubMed
17) 鈴木太. 学童期の注意欠陥多動性障害児における併存症. 児童青年精神医学とその近接領域 2005;46:35-48.
 
18) Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1995;34:886-896.
PubMed
19) Tannock R. Attention-deficit/hyperactivity disorder with anxiety disorders. In:Brown TE. Attention Deficit Disorder and Comorbidities in Children, Adolescents and Adults. New York:American Psychiatric Press;2000. pp125-170.
 
20) Taylor E, et al. Which boys respond to stimulant medication?:A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 1987;17:121-143.
PubMed
P.121 掲載の参考文献
1) Asami T, et al. Anterior cingulated cortex volume reduction in patients with panic disorder. Psychiatry Clin Neurosci 2008;62:322-330.
PubMed
2) Brand M, et al. Functional brain imaging in 14 patients with dissociative amnesia reveals right inferolateral prefrontal hypometabolism. Psychiatry Res 2009;174:32-39.
PubMed
3) Brunetti M, et al. Elevated response of human amygdala to neutral stimuli in mild post traumatic stress disorder:Neural correlates of generalized emotional response. Neuroscience 2010;168:670-679.
PubMed
4) Chen S, et al. Insular cortex involvement in declarative memory deficits in patients with posttraumatic stress disorder. BMC Psychiatry 2009;9:39.
PubMed
5) Elman I, et al. Functional neuroimaging of reward circuitry responsivity to monetary gains and losses in posttraumatic stress disorder. Biol Psychiatry 2009;66(12):1083-1090.
PubMed
6) Elzinga BM, et al. Neural correlates of enhanced working-memory performance in dissociative disorder:A functional MRI study. Psychol Med 2006;37:235-245.
PubMed
7) Falconer E, et al. The neural networks of inhibitory control in posttraumatic stress disorder. J Psychiatry Neurosci 2008;33:413-422.
PubMed
8) Felmingham KL, et al. Anterior cingulate activity to salient stimuli is modulated by autonomic arousal in posttraumatic stress disorder. Psychiatry Res 2009;173:59-62.
PubMed
9) Felmingham K, et al. Neural responses to masked fear faces:Sex differences and trauma exposure in posttraumatic stress disorder. Abnorm Psychol 2010;119(1):241-247.
PubMed
10) Fontaine R, et al. Temporal lobe abnormalities in panic disorder:An fMRI study. Biol Psychiatry 1990;27:304-310.
PubMed
11) Freitas-Ferrari MC, et al. Neuroimaging in social anxiety disorder:A systematic review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:565-580.
PubMed
12) Goosen L, et al. Amygdala hypoperfusion in phobic fear normalizes after exposure. Biol Psychiatry 2007;62:1119-1125.
 
13) Gorman JM, et al. Neuroanatomical hypothesis of panic disorder, revised. AM J Psychiatry 2000;157:493-505.
PubMed
14) Hayano F, et al. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin Neurosci 2009;63:266-276.
PubMed
15) Hermann A, et al. Diminished medial prefrontal activity in blood-injection injury phobia. Biol Psychol 2007;75:124-130.
PubMed
16) Larson CL, et al. Fear is fast in phobic individuals:Amygdala activation in response to fearrelevant stimuli. Biol Psychiatry 2006;60:410-417.
PubMed
17) Lucey JV, et al. Wisconsin Card Sorting Task(WCST) errors and cerebral blood flow in obsessive-compulsive disorder. Br J Med Psychol 1997;70:403-411.
PubMed
18) Maddock RJ, et al. Brain regions showing increased activation by threat-related words in panic disorder. Neuroreport 2003;14:325-328.
PubMed
19) Marchand WR, et al. An fMRI motor activation paradigm demonstrates abnormalities of putamen activation in females with panic disorder. J Affect Disord 2009;116:121-125.
PubMed
20) Martinot JL, et al. Obsessive-compulsive disorder:A clinical, neuropsychological and positron emission tomography study. Acta Psychiatr Scand 1990;82:233-242.
PubMed
21) Massana G, et al. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage 2003;19:80-90.
 
22) Monk CS, et al. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry 2008;65:568-576.
PubMed
23) Nakao T, et al. A functional MRI comparison of patients with obsessive-compulsive disorder and normal controls during a Chinese character Stroop task. Psychiatry Res 2005;139:101-114.
PubMed
24) Nakao T, et al. Working memory dysfunction in obsessive-compulsive disorder:A neuropsychological and functional MRI study. J Psychiatr Res 2009;43:784-791.
PubMed
25) 中尾智博. 強迫性障害と認知機能. 精神疾患と認知機能研究会(編). 精神疾患と認知機能. 東京:新興医学出版社;2009. pp218-225.
 
26) Nitschke JB, et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009;166:302-310.
PubMed
27) Page LA, et al. A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res 2009;174:202-209.
PubMed
28) Paulesu E, et al. Neural correlates of worry in generalized anxiety disorder and in normal controls:A functional MRI study. Psychol Med 2010;40(1):117-124.
PubMed
29) Pfleiderer B, et al. fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J Biol Psychiatry 2007;8:269-272.
 
30) Pillay SS, et al. fMRI of fearful facial affect recognition in panic disorder:The cingulate gyrusamygdala connection. J Affect Disord 2006;94:173-181.
PubMed
31) Pillay SS, et al. Recognition of happy facial affect in panic disorder:An fMRI study. J Anxiety Disord 2007;21:381-393.
PubMed
32) Protopopescu X, et al. Increased brainstem volume in panic disorder:A voxel-based morphometric study. Neuroreport 2006;17:361-363.
PubMed
33) Pujol J, et al. Functional magnetic resonance imaging study of frontal lobe activation during word generation in obsessive-compulsive disorder. Biol Psychiatry 1999;45:891-897.
PubMed
34) Schienle A, et al. Symptom provocation and reduction in patients suffering from spider phobia:An fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci 2007;257(8):486-493.
 
35) Shim G, et al. Reduced cortical folding of the anterior cingulate cortex in obsessive-compulsive disorder. J Psychiatry Neurosci 2009;34:443-449.
PubMed
36) Simmons A, et al. Anticipation of aversive visual stimuli is associated with increased insula activation in anxiety-prone subjects. Biol Psychiatry 2006;60(4):402-409.
PubMed
37) Sobanski T, et al. Temporal and right frontal lobe alterations in panic disorder:A quantitative volumetric and voxel-based morphometric MRI study. Psychol Med 2010;8:1-8.
 
38) Uchida RR, et al. Regional gray matter abnormalities in panic disorder:A voxel-based morphometry study. Psychiatry Res 2008;163:21-29.
PubMed
39) van der Wee NJ, et al. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage 2003;20:2271-2280.
PubMed
40) Vythilingam M, et al. Temporal lobe volume in panic disorder:A quantitative magnetic resonance imaging study. Psychiatry Res 2000;99:75-82.
PubMed
41) Wodbrock T, et al. Reduced prefrontal gyrification in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2010;in press.
 
42) Yoo HK, et al. Putaminal gray matter volume decrease in panic disorder:An optimazed voxelbased morphomatry study. Eur J Neurosci 2005;22:2089-2094.
 
P.129 掲載の参考文献
1) Cohen D, et al. Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders. J Child Adolesc Psychopharmacol 2010;20(1):39-47.
PubMed
2) Ipser JC, et al. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2009;8(3):CD005170.
 
3) RUPP Anxiety Study Group(The Research Units on Pediatric Psychopharmacology). Fluvoxamine treatment of anxiety disorder in children and adolescents. N Engl J Med 2001;344 (17):1279-1285.
 
4) Tamai Y, Matsumoto H. 11-year-old boy with panic disorder responding to paroxetine. Tokai J Exp Clin Med 2007;32(1):28-29.
PubMed
5) Uthman OA, Abdulmalik J. Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents:A mixed treatment comparison metaanalysis. Curr Med Res Opin 2010;26(1):53-59.
PubMed
6) Walkup JT, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359(26):2753-2766.
 
P.140 掲載の参考文献
1) Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007;46:267-283.
PubMed
2) Foa ED, Wilson R(片山奈緒美<訳>). 強迫性障害を自宅で治そう! -行動療法専門医がすすめる, 自分で治せる「3週間集中プログラム」. 東京:ヴォイス;2002.
 
3) Franklin ME, et al. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder:Randomized compared with nonrandomized samples. J Consult Clin Psychol 2000;68:594-602.
 
4) 原井宏明. 広場恐怖を含む恐慌性障害と強迫性障害, 恐怖症性障害. 大塚俊男ほか(編). エビデンス精神科医療I 気分・不安・人格の障害. 東京:日本評論社;1998. pp137-178.
 
5) 原井宏明. 第15章 動機づけ面接とACT ～MI ACTing? -私はACTしているのか? 武藤崇(編). アクセプタンス&コミットメントセラピーの文脈-臨床行動分析におけるマインドフルな展開. 東京:ブレーン出版;2006. pp289-310.
 
6) March JS, Mulle K. OCD in Children and Adolescents:A Cognitive-Behavioral Treatment Manual. New York:Guilford Press;1998/原井宏明, 岡嶋美代(訳). 認知行動療法による子どもの強迫性障害治療プログラム-OCDをやっつけろ-. 東京:岩崎学術出版社;2008.
 
7) Meyers RJ, et al. Community reinforcement and family training(CRAFT):Engaging unmotivated drug users in treatment. J Subst Abuse 1999;10:1-18.
 
8) Miller WR, Rollnick S. Motivational Interviewing:Preparing People for Change. New York:Guilford Press;2002.
 
9) 大野行弘. 不安障害にかかわる遺伝子と創薬へのアプローチ. 分子精神医学 2009;9(1):38-44.
Medical*Online
10) 岡嶋美代. イメージフラッディングと認知的対処方略に催眠を利用した恐怖症の二事例. 臨床催眠学 2007;8:46-54.
 
11) 岡嶋美代ほか. 強迫の診立てと治療. 強迫性障害の治療アウトカム. 精神科治療学 2007;22(5):509-516.
 
12) 岡嶋美代, 小松千沙都, 原井宏明. 強迫性障害-集団集中外来短期治療プログラム. 内山喜久雄, 坂野雄二(編). 認知行動療法の技法と臨床. 東京:日本評論社;2008. pp189-197.
 
13) 岡嶋美代, 原井宏明. 不安障害update. 強迫性障害. 心療内科 2008;12(6):457-464.
 
14) Scahill L, et al. Children's Yale-Brown Obsessive Compulsive Scale:Reliability and validity. J Am Acad Child Adolesc Psychiatry 1997;36:844-852.
 
15) Storch E, et al. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder:Comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007;46(4):469-478.
PubMed
OCDの会. とらわれからの自由. 2号. 熊本:OCDの会;2006. http://ocd-2004.hp.infoseek.co.jp/
 

III. 子どもの抑うつとその周辺

P.153 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision(DSM-IV-TR). Washington DC:American Psychiatric Association;2000.
 
2) Angold A, Costello EJ. Depressive comorbidity in children and adolescents:Empirical, theoretical, and methodological issues. Am J Psychiatry 1993;150:1779-1791.
PubMed
3) Carlson GA, Kashani JH. Phenomenology of major depression from childhood through adulthood:Analysis of three studies. Am J Psychiatry 1988;145:1222-1225.
PubMed
4) 傳田健三. 子どものうつ病-見逃されてきた重大な疾患. 東京:金剛出版;2002.
 
5) 傳田健三. 子どものうつ, 心の叫び. 東京:講談社;2004.
 
6) 傳田健三. SSRIの児童・青年期患者への投与と安全性. 小山司(編). SSRIのすべて. 東京:先端医学社;2007.
 
7) 傳田健三. 子どもの双極性障害. 児童青年精神医学とその近接領域(印刷中).
 
8) Emslie GJ, Rush AJ, Weinberg WA. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-1037.
PubMed
9) Fombonne E, Wostear G, Cooper V. The Maudsley long-term follow-up of child and adolescent depression. 1. Psychiatric outcomes in adulthood. Br J Psychiatry 2001;179:210-217.
PubMed
10) Harrington R. Affective disorders. In:Rutter M, Taylor E(eds).Child and Adolescent Psychiatry:Modern Approaches, 4th edition, Chapter 29. Oxford:Blackwell Science;2002. pp463-485/長尾圭造, 宮本信也(監訳). 児童精神医学. 東京:明石書店;2007.
 
11) Hasin DS, Goodwin RD, Stinson FS. Epidemiology of major depressive disorder:Results from the National Epidemiologic Survey on alcoholism and related conditions. Arch Gen Psychiatry 2005;62:1097-1106.
PubMed
12) Hazell P, O'Connell D, Heathcote D. Efficacy of tricyclic drugs in treating child and adolescent depression:A meta-analysis. Br Med J 1995;310:897-901.
 
13) Keller MB, Ryan ND, Strober M. Efficacy of paroxetine in the treatment of adolescent major depression:A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-772.
PubMed
14) National Collaborating Center for Mental Health. Depression in children and young people:Identification and management in primary, community and secondary care. National Institute for Health and Clinical Excellence, National Clinical Practice Guideline 28. London:NICE;2005. www.nice.org.uk/
 
15) Ryan ND, Puig-Antich J, Ambrosini P. The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 1987;44:854-861.
PubMed
16) Treatment for Adolescents with Depression Study(TADS) Team. Fluoxetine, cognitivebehavioral therapy, and their combination for adolescents with depression:Treatment for Adolescents with Depression Study(TADS) randomized controlled trial. JAMA 2004;292:807-820.
PubMed
17) Wagner KD, Ambrosini P, Rynn M. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder:Two randomized controlled trials. JAMA 2003;290:1091-1093.
 
18) Wagner KD, Robb AS, Findling RL. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161:1079-1083.
PubMed
19) Watanabe N, Hunot V, Omori I. Psychotherapy for depression among children and adolescents:A systematic review. Acta Psychiatr Scand 2007;116:84-95.
PubMed
P.164 掲載の参考文献
1) Berard R, et al. An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2006;16(1-2):59-75.
PubMed
2) Brent D, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression:The TORDIA randomized controlled trial. JAMA 2008;299(8):901-913.
 
3) Desarkar P, Das A, Sinha VK. Duloxetine for childhood depression with pain and dissociative symptoms. Eur Child Adolesc Psychiatry 2006;15(8):496-499.
PubMed
4) Emslie GJ, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-1037.
PubMed
5) Emslie GJ, et al. Fluoxetine for acute treatment of depression in children and adolescents:A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-1215.
PubMed
6) Emslie GJ, et al. Paroxetine treatment in children and adolescents with major depressive disorder:A randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2006;45(6):709-719.
 
7) Emslie GJ, et al. Venlafaxine ER for the treatment of pediatric subjects with depression:Results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2007;46(4):479-488.
PubMed
8) Gibbons RD, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164(9):1356-1363.
PubMed
9) Haapasalo-Pesu KM, et al. Mirtazapine in the treatment of adolescents with major depression:An open-label, multicenter pilot study. J Child Adolesc Psychopharmacol 2004;14(2):175-184.
PubMed
10) Hammad TA, et al. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63(3):246-248.
 
11) Hughes CW, et al. Texas Children's Medication Algorithm Project:Update from Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 2007;46(6):667-686.
 
12) Keller MB, et al. Efficacy of paroxetine in the treatment of adolescent major depression:A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-772.
PubMed
13) Mandoki MW, et al. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull 1997;33:149-154.
PubMed
14) March J, et al. Treatment for Adolescents with Depression Study(TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression:TADS randomized controlled trial. JAMA 2004;292(7):807-820.
PubMed
15) Meighen KG. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder. J Child Adolesc Psychopharmacol 2007;17(1):121-127.
PubMed
16) Open-Label Study of Duloxetine in the Treatment of Children and Adolescents with Major Depressive Disorder. http://clinicaltrials.gov/ct2/show/NCT00529789
 
17) Organon Pharmaceuticals USA, INC. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Remeron(R) in Outpatient Children and Adolescents with Major Depressive Disorder 2001. http://www.clinicalstudyresults.org
 
18) 齊藤卓弥, 西松能子. 児童思春期うつ病の治療-過去10年間の対照試験の結果の検討. 精神科治療学 2005;20(4):421-433.
 
19) 齊藤卓弥. 精神科における症候・症候群の治療指針-子どもの気分障害. 臨床精神医学 2006;増刊:327-333.
 
20) 齊藤卓弥. 児童精神科領域における薬物療法. 日本児童青年精神医学会(監修) . 児童青年精神医学セミナーI. 東京:金剛出版;2009. pp173-198.
 
21) Simeon JG, et al. Adolescent depression:A placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990;14(5):791-795.
PubMed
22) Tsapakis EM, et al. Efficacy of antidepressants in juvenile depression:Meta-analysis. Br J Psychiatry 2008;193(1):10-17.
PubMed
23) Usala T, et al. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents:A systematic review and meta-analysis. Eur Neuropsychopharmacol 2008;18(1):62-73.
PubMed
24) von Knorring AL, et al. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006;26(3):311-315.
PubMed
25) Wagner KD, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder:Two randomized controlled trials. JAMA 2003;290:1033-1041.
PubMed
26) Wagner KD, Robb AS. Randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161:1079-1083.
PubMed
27) Wagner KD, et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45(3):280-288.
PubMed
28) Wagner KD, et al. An update on depression in children and adolescents. J Clin Psychiatry 2008;69(11):1818-1828.
 
P.174 掲載の参考文献
1) Angold A, Costello EJ, Worthman CM. Puberty and depression:The roles of age, pubertal status and pubertal timing. Psychol Med 1998;28:51-61.
PubMed
2) Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry 1999;40:57-87.
PubMed
3) Avenevoli S, et al. Comorbidity of depression in children and adolescents:Models and evidence from a prospective high-risk family study. Biol Psychiatry 2001;49:1071-1081.
PubMed
4) Burke KC, et al. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry 1990;47:511-518.
PubMed
5) Costello EJ, Foley DL, Angold A. 10-year research update review:The epidemiology of child and adolescent psychiatric disorders:II. Developmental epidemiology. J Am Acad Child Adolesc Psychiatry 2006;45:8-25.
PubMed
6) Costello EJ, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 2006;47:1263-1271.
 
7) Cyranowski JM, et al. Adolescent onset of the gender difference in lifetime rates of major depression:A theoretical model. Arch Gen Psychiatry 2000;57:21-27.
PubMed
8) 傳田健三ほか. 小・中学生の抑うつ状態に関する調査-Birleson自己記入式抑うつ評価尺度(DSRS-C)を用いて. 児童青年精神医学とその近接領域 2004;45:424-436.
 
9) Doi Y, et al. Multiethnic comparison of adolescent major depression based on the DSM-IV criteria in a U.S.-Japan study. J Am Acad Child Adolesc Psychiatry 2001;40:1308-1315.
 
10) Egger HL, Angold A. Common emotional and behavioral disorders in preschool children:Presentation, nosology, and epidemiology. J Child Psychol Psychiatry 2006;47:313-337.
PubMed
11) Feehan M, et al. DSM-III-R disorders in New Zealand 18-year-olds. Aust N Z J Psychiatry 1994;28:87-99.
PubMed
12) Gotlib IH, Hammen CL. Psychological aspects of depression:Toward a cognitive-interpersonal integration. Chichester, England UK:John Wiley & Sons:1992.
 
13) Hammen C, Rudolph KD. Childhood depression. In:Mash EJ, Barkley RA(eds). Child Psychopathology. New York:Guilford Press;1996. pp153-195.
 
14) Harrington R, et al. Adult outcomes of childhood and adolescent depression. I. Psychiatric status. Arch Gen Psychiatry 1990;47:465-473.
PubMed
15) Kashani JH, Orvaschel H. A community study of anxiety in children and adolescents. Am J Psychiatry 1990;147:313-318.
PubMed
16) Kawakami N, et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan:Preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci 2005;59:441-452.
PubMed
17) Kessler RC, et al. Sex and depression in the National Comorbidity Survey. I:Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
PubMed
18) Kessler RC, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States:Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8- 19.
 
19) Kessler RC. Epidemiology of psychiatric comorbidity. In:Tsuang MT, et al(eds). Textbook in Psychiatric Epidemiology. New York:Wiley-Liss;1995. pp179-198.
 
20) Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents:An epidemiologic perspective. Biol Psychiatry 2001;49:1002-1014.
PubMed
21) Kessler RC. Epidemiology of women and depression. J Affect Disord 2003;74:5-13.
PubMed
22) Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
PubMed
23) Kessler RC, et al. Age of onset of mental disorders:A review of recent literature. Curr Opin Psychiatry 2007;20:359-364.
PubMed
24) Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007;6:168-176.
PubMed
25) Kovacs M, et al. Depressive disorders in childhood. I.A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 1984;41:229-237.
 
26) Lewinsohn PM, Hoberman HM, Rosenbaum M. A prospective study of risk factors for unipolar depression. J Abnorm Psychol 1988;97:251-264.
 
27) Lewinsohn PM, et al. Comorbidity of unipolar depression:I. Major depression with dysthymia. J Abnorm Psychol 1991;100:205-213.
PubMed
28) Lewinsohn PM, et al. Adolescent psychopathology:I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993;102:133-144.
PubMed
29) Lewinsohn PM, et al. Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents. J Anxiety Disord 1997;11:377-394.
PubMed
30) Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents:Prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18:765-794.
PubMed
31) Luby JL, et al. Preschool major depressive disorder:Preliminary validation for developmentally modified DSM-IV criteria. J Am Acad Child Adolesc Psychiatry 2002;41:928-937.
PubMed
32) Luby JL, et al. Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry 2003;60:1248-1255.
PubMed
33) Luby JL, et al. The clinical picture of depression in preschool children. J Am Acad Child Adolesc Psychiatry 2003;42:340-348.
PubMed
34) Merikangas K, Pollock R. Anxiety disorders in women. In:Goldman MB, Hatch MC(eds). Women and Health. San Diego:Academic Press;2000. pp1010-1023.
 
35) Merikangas KR, Weissman MM, Pauls DL. Genetic factors in the sex ratio of major depression. Psychol Med 1985;15:63-69.
PubMed
36) Merikangas KR. Epidemiology of mood disorders in women. In:Steiner M, et al(eds). Mood Disorders in Women. London:Martin Dunitz;2000. pp1-14.
 
37) Merikangas KR, Avenevoli S. Epidemiology of mood and anxiety disorders in children and adolescents. In:Tsuang MT, Tohen M(eds). Textbook in Psychiatric Epidemiology, 2nd edition. New York:Wiley-Liss;2002. pp657-704.
 
38) Merikangas KR, Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr Opin Psychiatry 2007;20:353-358.
PubMed
39) Mitchell J, et al. Psychopathology in parents of depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 1989;28:352-357.
PubMed
40) Newman DL, et al. Psychiatric disorder in a birth cohort of young adults:Prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. J Consult Clin Psychol 1996;64:552-562.
 
41) Nolen-Hoeksema S, Girgus JS. The emergence of gender differences in depression during adolescence. Psychol Bull 1994;115:424-443.
PubMed
42) Orvaschel H, Lewinsohn PM, Seeley JR. Continuity of psychopathology in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry 1995;34:1525-1535.
 
43) Pine DS, et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998;55:56-64.
PubMed
44) Reinherz HZ, et al. The relationship of early risk and current mediators to depressive symptomatology in adolescence. J Am Acad Child Adolesc Psychiatry 1989;28:942-947.
PubMed
45) Rohde P, Lewinsohn PM, Seeley JR. Comorbidity of unipolar depression:II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol 1991;100:214-222.
PubMed
46) 佐藤寛, 下津咲絵, 石川信一. 一般中学生におけるうつ病の有病率-半構造化面接を用いた実態調査. 精神医学 2008;50:439-448.
 
47) Simonoff E, et al. The Virginia Twin Study of Adolescent Behavioral Development:Influences of age, sex, and impairment on rates of disorder. Arch Gen Psychiatry 1997;54:801-808.
PubMed
48) Sugawara M, et al. Psychiatric disorders among Japanese children. J Am Acad Child Adolesc Psychiatry 1999;38:444-452.
 
49) 立森久照. こころの健康についての疫学調査(世界精神保健日本調査)の主要成果. 平成16～18年度厚生労働科学研究費補助金(こころの健康科学事業)「心の健康についての疫学調査に関する研究」総合研究報告書(主任研究者 川上憲人). 2007. pp35-75.
 
50) Tsuchiya M, et al. Lifetime comorbidities between phobic disorders and major depression in Japan:Results from the World Mental Health Japan 2002-2004 Survey. Depress Anxiety 2009;26:949-955.
PubMed
51) Twenge JM, Nolen-Hoeksema S. Age, gender, race, socioeconomic status, and birth cohort differences on the children's depression inventory:A meta-analysis. J Abnorm Psychol 2002;111:578-588.
 
52) Wichstrom L. The emergence of gender difference in depressed mood during adolescence:The role of intensified gender socialization. Dev Psychol 1999;35:232-245.
PubMed
53) Wittchen HU, Stein MB, Kessler RC. Social fears and social phobia in a community sample of adolescents and young adults:Prevalence, risk factors and co-morbidity. Psychol Med 1999;29:309-323
 
54) Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe:A critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005;15:357-376.
PubMed
P.187 掲載の参考文献
1) Cohen IL, Tsiouris JA. Maternal recurrent mood disorders and high-functioning autism. J Autism Dev Disord 2006;36:1077-1088.
PubMed
2) Delong GR, Ritch CR, Bursch SA. Fluoxetine response in children with autistic spectrum disorders:Correlation with familial major affective disorder and intellectual achievement. Dev Med Child Neurol 2002;44:652-659.
 
3) Frazier JA, et al. Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry 2002;159(1):13-21.
PubMed
4) Ghaziuddin M, Weidmer-Mikhail E, Ghaziuddin N. Comorbidity of Asperger syndrome:A preliminary report. J Intellect Disabil Res 1998;42:279-283.
PubMed
5) Grandin T,Scariano M. Emergence:Labeled Autisitc. Novato, California:Arena Press;1986/カニングハム久子(訳). 我, 自閉症に生まれて. 東京:学習研究社;1993.
 
6) Kobayashi R, Murata T, Yoshinaga K. A follow-up study of 201 children with autism in Kyushu and Yamaguchi areas, Japan. J Autism Dev Disord 1992;22(3):395-411.
PubMed
7) Komoto J, Usui S. Infantile autism and affective disorder. J Autism Dev Disord 1984;14(1):81-84.
PubMed
8) Lajiness-O'Neill R, Menard P. Brief report:An autisitc spectrum subtype revealed through familial psychopathology coupled with cognition in ASD. J Autism Dev Disord 2008;38:982-987.
 
9) McCauley JL, et al. Linkage and association analysis at the serotonin transporter(SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet 2004;127:104-112.
 
10) Mouridsen SE, Rich B, Isager T. Psychiatric disorders in adults as diagnosed as children with atypical autism:A case control study. J Neural Transm 2008;115:135-138.
PubMed
11) Munesue T, et al. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high functioning autism spectrum disorder:A preliminary study of 44 outpatients. J Affect Disord 2008;111:170-175.
 
12) 並木典子, 杉山登志郎, 明翫光宣. 高機能広汎性発達障害にみられる気分障害に関する臨床研究. 小児の精神と神経 2006;46(4):257-263.
 
13) Piven J, et al. Broader autism phenotype:Evidence from a family history study of multiple incidence autism families. Am J Psychiatry 1997;154:185-190.
PubMed
14) Rutgers AH, et al. Autism and attachment:A meta-analytic review. J Child Psychol Psychiatry 2004;45:1123-1134.
PubMed
15) Shtayermman O. Peer victimaization in adolescents and young adults diagnosed with Asperger's syndrome:A link to depressive symptomatology, anxiety symptomatology and suicidal ideation. Issues Compr Pediatr Nurs 2007;30(Suppl 2):87-107.
 
16) Sofronoff K, et al. A randomized controlled trial of a cognitive behavioural intervention for anger management in children diagnosed with Asperger syndrome. J Autism Dev Disord 2007;37:1203-1214.
PubMed
17) Sterling L, et al. Characteristics associated with presence of depressive symptoms in adults with autism spectrum disorder. J Autism Dev Disord 2008;38(6):1011-1018.
PubMed
18) 高岡健, 関正樹. 自閉症スペクトラムの1症例にみられた気分障害とカタトニー. 臨床精神医学 2005;34:1157-1162.
Medical*Online
19) Taylor EL, Target M, Charman T. Attachment in adults with high-functioning autism. Attach Hum Dev 2008;10(2):143-163.
PubMed
20) Tustin F. Autism and Childhood Psychosis. London:Karnac Books;1972/斎藤久美子(監修), 平井正三(監訳). 自閉症と小児精神病. 大阪:創元社;2005.
 
21) Williams D. Exposure Anxiety-The Invisible Cage:An Exploration of Self-Protection Responses in the Autism Spectrum and Beyond. London, Philadelphia:Jessica Kingsley;2003.
 
22) 山下洋. 子どもと家族の発達と強迫性障害-養育行動と愛着の視点から. こころの科学 2007;134:72-78.
 
P.197 掲載の参考文献
1) AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision(DSM-IV-TR). Washington DC:American Psychiatric Association;2000/高橋三郎, 大野裕, 染矢俊幸(訳). DSM-IV-TR精神疾患の診断・統計マニュアル. 東京:医学書院;2002.
 
3) Barkley RA. Attention-Deficit Hyperactive Disorder, 2nd edition. New York:Guilford Press;1998.
 
4) Barkley RA. Attention-Deficit Hyperactive Disorder, 3rd edition. New York:Guilford Press;2006.
 
5) Biederman J, et al. High rate of affective disorders in probands with attention deficit disorder and in their relatives:A controlled family study. Am J Psychiatry 1987;144:330-333.
PubMed
6) Biederman J, et al. Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 1991;48:633-642.
PubMed
7) Biederman J, et al. Psychiatric comorbidity among referred juveniles with major depression:Fact or artifact? J Am Acad Child Adolesc Psychiatry 1995;34:579-590.
PubMed
8) Biederman J. A 55-year-old man with attention deficit/hyperactivity disorder. JAMA 1998;280:1086-1092.
 
9) Biederman J, et al. Pediatric mania:A developmental subtype of bipolar disorder? Biol Psychiatry 2000;48:458-466.
 
10) Dulcan MK, et al. Practice parameter for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36(10 Suppl):85S-121S.
 
11) 榎戸芙佐子. 注意欠陥多動障害(ADHD)の臨床的研究. 金医大誌 2000;25:119-134.
 
12) Geller B, Luby J. Child and adolescent bipolar disorder:A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997;36:1168-1176.
PubMed
13) Hughes CW, et al. Texas children's medication algorithm project:Update from Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 2007;46(6):667-686.
 
14) 飯田順三. 他の精神疾患との鑑別. 齊藤万比古, 渡部京太(編). 第3版 注意欠如/多動性障害-ADHD-の診断・治療ガイドライン. 東京:じほう;2008. pp100-104.
 
15) Ishii T, et al. Comorbidity in attention deficit-hyperactivity disorder. Psychiatry Clin Neurosci 2003;57:457-463.
PubMed
16) James A, Lai FH, Dahl C. Attention deficit hyperactivity disorder and suicide:A review of possible associations. Acta Psychiatrica Scandinavica 2004;110:405-415.
 
17) 加藤忠史, 金生由紀子. 小児・思春期の双極性障害-近年の増加の要因について. 臨床精神医学 2006;35:1399-1405.
Medical*Online
18) Pliszka SR, et al. The Texas Children's Medication Algorithm Project:Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. J Am Acad Child Adolesc Psychiatry 2000;39:908-919.
 
19) Pliszka SR, et al. The Texas Children's Medication Algorithm Project:Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45:642-657.
 
20) Pliszka SR. Treating ADHD and Comorbid Disorders. New York:Guilford Press;2009.
 
21) 齊藤万比古. 注意欠陥/多動性障害(ADHD)とその併存障害-人格発達上のリスク・ファクターとしてのADHD. 小児の精神と神経 2000;40:243-254.
 
22) 齊藤万比古ほか. 注意欠陥/多動性障害に伴う併存障害の診断・病態・治療に関する研究(3) 三年間のまとめ. 厚生労働省精神・神経疾患研究委託費による11-13年度研究報告書. 注意欠陥/多動性障害の診断・治療ガイドライン作成とその実証的研究. 2002. pp51-57.
 
23) 齊藤万比古ほか. 注意欠陥/多動性障害(ADHD)の子どもの中期的予後についての研究. 齊藤万比古(主任研究者). 厚生労働省「精神・神経疾患研究委託費」14指-8 注意欠陥/多動性障害の総合的評価と臨床的実証研究 平成14年度-16年度研究報告書. 2005. pp217-233.
 
24) 齊藤万比古, 渡部京太(編). 第3版 注意欠如/多動性障害-ADHD-の診断・治療ガイドライン. 東京:じほう;2008.
 
25) 齊藤卓弥. 子どもの気分障害. 臨床精神医学 2006;35(増刊号):327-331.
 
26) 鈴木太. 学童期の注意欠陥多動性障害児における併存症. 児童青年精神医学とその近接領域 2005;46:35-48.
 
27) Taylor E. Hyperkinetic disorders. In:Gilberg C, Steinhausen HC, Harrington R(eds). A Clinician's Handbook of Child and Adolescent Psychiatry. New York:Cambridge Univ Press;2006. pp489-521.
 
28) 牛島洋景, 宇佐美政英, 齊藤万比古. 発達障害のうつ病. 神庭重信, 黒木俊秀(編). 現代うつ病の臨床-その多様な病態と自在な対処法. 大阪:創元社;2009. pp229-244.
 
29) 渡部京太. 問題行動のために入院治療が必要になった注意欠陥多動性障害(ADHD)の子どもへの対応. 児童青年精神医学とその近接領域 2007;48:264-275.
 
30) Weiss M, Weiss G. Attention deficit hyperactivity disorder. In:Lewis M(ed). Child and Adolescent Psychiatry:A Comprehensive Textbook, 3rd edition. Philadelphia:Lippincott Williams & Wilkins;2002. pp645-670.
 
P.204 掲載の参考文献
1) Akiskal HS, et al. Switching from ‘unipolar' to bipolar II:An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995;52:114-123.
 
2) Caspi A, et al. Influence of life stress on depression:Moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389.
PubMed
3) Chen MC, Hamilton JP, Gotlib IH. Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 2010;67:270-276.
PubMed
4) Eley TC, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004;9:908-915.
PubMed
5) 福田正人. 画像研究. 上島国利ほか(編). 気分障害. 東京:医学書院;2008. pp223-233.
 
6) 井上猛. 不安と抑うつ-情動の神経回路の視点から. Depression and Anxiety-診断・病態レベル・治療の側面から. 東京:アルタ出版;2009. pp35-40.
 
7) Ising M, et al. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1085-1093.
PubMed
8) Kaufman J, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004;101:17316-17321.
PubMed
9) Kiejna A, et al. Bipolar or unipolar?:The question for clinicians and researchers. J Affect Disord 2006;93:177-183.
 
10) Konarski JZ, et al. Volumetric neuroimaging investigations in mood disorders:Bipolar disorder versus major depressive disorder. Bipolar Disord 2008;10:1-37.
PubMed
11) Kunugi H, et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal(HPA) axis abnormalities in major depressive episode:A multicenter study. Neuropsychopharmacology 2006;31:212-220.
PubMed
12) MacMaster FP, et al. Amygdala and hippocampal volumes in familial early onset major depressive disorder. Biol Psychiatry 2008;63:385-390.
PubMed
13) 大塚達以, 須原哲也. 画像研究. 上島国利ほか(編). 気分障害. 東京:医学書院;2008. pp271-281.
 
14) 尾崎紀夫, 吉田契造. 画像研究. 上島国利ほか(編). 気分障害. 東京:医学書院;2008. pp201-218.
 
15) Rao U, Chen LA. Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders. Dialogues Clin Neurosci 2009;11:45-62.
PubMed
16) Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications:Meta-analyses and implications. Biol Psychiatry 2008;64:527-532.
PubMed
17) Sexton CE, Mackay CE, Ebmeier KP. A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry 2009;66:814-823.
PubMed
18) Thomas KM, et al. Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 2001;58:1057-1063.
PubMed
19) Zalsman G, et al. Neurobiology of depression in children and adolescents. Child Adolesc Psychiatr Clin N Am 2006;15:843-868, vii-viii.
 
P.223 掲載の参考文献
1) Chiles JA, Strosahl KD. Clinical Manual for Assessment and Treatment of Suicidal Patients. Washington DC:American Psychiatric Publishing;2005/高橋祥友(訳). 自殺予防臨床マニュアル. 東京:星和書店;2008.
 
2) Hawton K, Rodham K, Evans E. By Their Own Young Hand:Deliberate Self-Harm and Suicidal Ideas in Adolescents. London:Jessica Kingsley Publishers;2006/松本俊彦ほか(監訳). 自傷と自殺-思春期における予防と介入の手引き. 東京:金剛出版;2008.
 
3) 廣川聖子ほか. 死亡前に精神科治療を受けていた自殺既遂者の心理社会的特徴-心理学的剖検による調査. 日本社会精神医学会雑誌 2010;18:341-351.
Medical*Online
4) 松本俊彦, 山口亜希子. 嗜癖としての自傷行為. 精神療法 2005;31:329-332.
 
5) 松本俊彦. 解離をめぐる青年期症例の治療-解離性自傷患者の理解と対応. 精神科治療学 2007;22:311-318.
 
6) Matsumoto T, Imamura F. Self-injury in Japanese junior and senior high-school students:Prevalence and association with substance use. Psychiatry Clin Neurosci 2008;62:123-125.
PubMed
7) 松本俊彦. 自傷のアセスメント. 臨床心理学 2008;8:482-488.
 
8) 松本俊彦, 今村扶美, 勝又陽太郎. 児童・生徒の自傷行為に対応する養護教諭が抱える困難について-養護教諭研修会におけるアンケート調査から. 精神医学 2009;51:791-799.
 
9) 松本俊彦. リストカッターの自殺. 精神科治療学2010;25:237-245.
 
10) Miller TR, Taylor DM. Adolescent suicidality:Who will ideate, who will act? Suicide Life Threat Behav 2005;35:425-435.
PubMed
11) 内閣府. 自殺対策加速化プラン. http://www8.cao.go.jp/jisatsutaisaku/taikou/pdf/plan.pdf
 
12) 内閣府. 平成20年度版 自殺総合対策白書. 東京:佐伯印刷;2008.
 
13) 内閣府. 平成21年度版 自殺総合対策白書. 東京:佐伯印刷;2009.
 
14) Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm:Systematic review. Br J Psychiatry 2002;181:193-199.
PubMed
15) Pfeffer CR. The Suicidal Child. New York:Guilford Press;1986/高橋祥友(訳). 死に急ぐ子供たち-小児の自殺の臨床精神医学的研究. 東京:中央洋書出版部;1990.
 
16) Walsh BW. Treating Self-Injury. New York:Guilford Press;2005/松本俊彦ほか(訳). 自傷行為治療ガイド. 東京:金剛出版;2007.
 
17) 山口亜希子, 松本俊彦. 女子高校生における自傷行為-喫煙・飲酒, ピアス, 過食傾向との関係. 精神医学 2005;47:515-522.
 
P.233 掲載の参考文献
1) Gillberg C. A Guide to Asperger Syndrome. London:Cambrige University Press;2002/田中康雄(監), 森田由美(訳). アスペルガー症候群がわかる本-理解と対応のためのガイドブック. 東京:明石書店;2003.
 
2) Gould MS, et al. Youth suicide risk and preventive interventions:A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2003;42:386-405.
 
3) 人見佳枝, 白川治. 発達障害における自殺企図. 精神科 2009;14:163-166.
 
4) Honda H, et al. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry 1996;169:228-235.
PubMed
5) James A, Lai FH, Dahl C. Attention deficit hyperactivity disorder and suicide:A review of possible associations. Acta Psychiatr Scand 2004;110:408-415.
PubMed
6) 警察庁生活安全局地域課. 平成20年中における自殺の概要資料. http://www.npa.go.jp/safetylife/seianki81/210514_H20jisatsunogaiyou.pdf
 
7) 厚生労働省大臣官房統計情報部人口動態・保健統計課. 自殺死亡統計の概況. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/tokusyu/suicide04/index.html
 
8) 厚生統計協会. 国民衛生の動向. 厚生の指標 2008;55:406-408.
 
9) 松嶋圭ほか. 思春期・青年期になって自傷・暴力等を呈したアスペルガー障害の4症例. 九州神経精神医学 2003;49:81-89.
 
10) 三上克央, 大屋彰利, 松本英夫. 父子への治療的介入が奏効した大うつ病を合併した児童期アスペルガー障害の1症例. 臨床精神医学 2005;34:1293-1299.
Medical*Online
11) 三上克央ほか. 思春期における自殺企図の臨床的検討-入院を必要とした症例を中心に. 精神医学 2006;48:1199-1206.
 
12) 三上克央ほか. 青年期アスペルガー障害における自殺企図の1例. 精神神経学雑誌 2006;108:587-596.
 
13) 三上克央, 岸泰宏, 松本英夫. 思春期における自殺企図の1例-背景となった心理・社会的準備因子の認識と介入の重要性を中心に. 精神医学 2006;48:331-338.
 
14) Mikami K, et al. Frequency and clinical features of pervasive developmental disorder in adolescent suicide attempts. Gen Hosp Psychiatry 2009;31:163-166.
PubMed
15) 三上克央ほか. 思春期自殺企図例に対する自殺再企図防止のための家族アプローチ-長年の家族背景が自殺準備因子である事例への試み. 家族療法研究 2009;26:56-64.
 
16) 三上克央. 発達障害の自殺. 精神科治療学 2010;25:199-205.
 
17) Murase S, et al. Clinical characteristics of serious Japanese adolescent suicide-attempters admitted to an intensive care ward. Jpn J Child Adolesc Psychiatr 2004;45:25-34.
 
18) Stewart SE, et al. Suicidal children and adolescents with first emergency room presentations:Predictors of six-month outcome. J Am Acad Child Adolesc Psychiatry 2001;40:580-587.
PubMed
19) 栃本真一ほか. 救急対応が必要であった青年期・成人期広汎性発達障害-5症例の経験をもとに. 臨床精神医学 2001;30:297-303.
Medical*Online
20) Wing L. Asperger's syndrome:A clinical account Psychol Med 1981;11:115-129.
PubMed
P.241 掲載の参考文献
1) Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter:II. Suicidal behavior. Mol Psychiatry 2003;8(7):646-653.
PubMed
2) Asberg M, et al. Serotonin depression:A biochemical subgroup within the affective disorders? Science 1976;191(4226):478-480.
PubMed
3) Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid:A biochemical suicide predictor? Arch Gen Psychiatry 1976;33(10):1193-1197.
PubMed
4) Baldessarini RJ, Hennen J. Genetics of suicide:An overview. Harv Rev Psychiatry 2004;12 (1):1-13.
PubMed
5) Belda X, et al. Exposure to severe stressors causes long-lasting dysregulation of resting and stress-induced activation of the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci 2008;1148:165-173.
PubMed
6) Berk M, Dodd S. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression? Med Hypotheses 2005;65(1):39-43.
PubMed
7) Brent DA, et al. Age-and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry 1999;38(12):1497-1505.
PubMed
8) Brent DA. Antidepressants and pediatric depression:The risk of doing nothing. N Engl J Med 2004;351(16):1598-1601.
PubMed
9) Brodsky BS, Mann JJ, Stanley B. Familial transmission of suicidal behavior:Factors mediating the relationship between childhood abuse and offspring suicide attempts. Clin Psychiatry 2008;69(4):584-596.
PubMed
10) Correa H, et al. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 2000;93(3):189-199.
 
11) Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001;158(5):748-753.
PubMed
12) Cremniter D, et al. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol Psychiatry 1999;45(12):1572-1579.
PubMed
13) Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am 2008;31(2):247-269.
PubMed
14) Dahl RE, et al. EEG sleep in adolescents with major depression:The role of suicidality and inpatient status. J Affect Disord 1990;19(1):63-75.
 
15) Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol 2009;89(4):315-333.
PubMed
16) Fukutake M, et al. Association of α2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(6):1428-1433.
 
17) Garcia-Sevilla JA, et al. Up-regulation of immunolabeled α2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem 1999;72(1):282-291.
 
18) Garfinkel BD, Froese A, Hood J. Suicide attempts in children and adolescents. Am J Psychiatry 1982;139(10):1257-1261.
PubMed
19) Greenhill L, et al. Biological studies in suicidal adolescent patients. Proceedings of the 42nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans, LA, October. 1995. pp17-22.
 
20) Hishimoto A, et al. Association between a functional polymorphism in the renin-angiotensin system and completed suicide. J Neural Transm 2006;113(12):1915-1920.
PubMed
21) Hishimoto A, et al. A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J Neural Transm 2008;115(3):531-536.
PubMed
22) Lewinsohn PM, Rohde P, Seeley JR. Adolescent suicidal ideation and attempts:Prevalence, risk factors, and clinical implications. Clin Psychol Sci Prac 1996;3(1):25-36.
 
23) Malone KM, et al. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996;168(3):324-329.
PubMed
24) Mann JJ, et al. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 1995;13(1):53-64.
PubMed
25) Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4(10):819-828.
PubMed
26) Mann JJ, Arango VA, Avenevoli S. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 2009;65(7):556-563.
PubMed
27) Meana JJ, Garcia-Sevilla JA. Increased α2-adrenoceptor density in the frontal cortex of depressed suicide victims. J Neural Transm 1987;70(3-4):377-381.
 
28) Meyer JH, et al. The effect of paroxetine on 5-HT(2A) receptors in depression:An[(18) F] setoperone PET imaging study. Am J Psychiatry 2001;158(1):78-85.
PubMed
29) Muldoon MF, et al. Cholesterol reduction and non-illness mortality:Meta-analysis of randomised clinical trials. BMJ 2001;322(7277):11-15.
PubMed
30) 西口直希, 白川治. 自殺への生物学的アプローチとその成果. 精神医学 2009;51(11):1069-1074.
 
31) Ono H, et al. Association between catechol-O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology 2004;29(7):1374-1377.
PubMed
32) Pfeffer CR, Stokes P, Shindledecker R. Suicidal behavior and hypothalamic-pituitaryadrenocortical axis indices in child psychiatric inpatients. Biol Psychiatry 1991;29(9):909-917.
 
33) Roy A, et al. Suicide in twins. Arch Gen Psychiatry 1991;48(1):29-32.
PubMed
34) Roy A, Segal NL, Sarchiapone M. Attempted suicide among living co-twins of twin suicide victims. Am J Psychiatry 1995;152(7):1075-1076.
PubMed
35) Schulsinger R, et al. A family study of suicide. In:Schou M, Stromgren E(eds). Origins, Prevention and Treatment of affective Disorders. New York:Academic Press;1979. pp277-287.
 
36) Virkkunen M. Serum cholesterol in antisocial personality. Neuropsychobiology 1979;5(1):27-30.
PubMed

IV. 関連する領域

P.257 掲載の参考文献
1) Atkinson L, Quarrington B. School refusal:The heterogeneity of a concept. Am J Orthopsychiatry 1985;55:83-101.
PubMed
2) Atkinson L, et al. Differential classification in school refusal. Br J Psychiatry 1989;155:191-195.
PubMed
3) Berg I. School refusal in early adolescence. In:Hersov L, Berg I(eds). Out of School. Chichester:John Wiley & Sons;1980. pp231-249.
 
4) Bernstein GA, Layne AE. Separation anxiety disorder and generalized anxiety disorder. In:Wiener JM, Dulcan MK(eds). Textbook of Child and Adolescent Psychiatry, 3rd editon. Washington DC:American Psychiatric Publishing;2004. pp557-573.
 
5) Blos P. On Adolescence:A Psychoanalytic Interpretation. New York, London:The Free Press;1962/野沢栄司(訳). 青年期の精神医学. 東京:誠信書房;1971.
 
6) Blos P. The second individuation process of adolescence. Psychoanal Study Child 1967;22:162-186.
PubMed
7) Broadwin IT. A contribution to the study of truancy. Am J Orthopsychiatry 1932;2:253-259.
 
8) Hersov LA. Persistent non-attendance at school. J Child Psychol Psychiatry 1960;1:130-136.
 
9) Johnson AM, et al. School phobia. Am J Orthopsychiatry 1941;11:702-708.
 
10) 栗田広ほか. DSM-III診断基準の適用とその問題点-その15 "登校拒否"の診断学的分類. 臨床精神医学 1982;11:87-95.
 
11) 齊藤万比古. 不登校の病院内学級中学校卒業後10年間の追跡研究. 児童青年精神医学とその近接領域 2000;41:377-399.
 
12) 齊藤万比古. 最近の不登校. 臨床精神医学 2004;33:373-378.
Medical*Online
13) 齊藤万比古(編). 不登校対応ガイドブック. 東京:中山書店;2007.
 
14) 齊藤万比古. 不登校. 児童青年精神医学とその近接領域 2009;50(50周年記念特集号):145-155.
 
15) 齊藤万比古(研究代表者). 厚生労働科学研究費補助金こころの健康科学研究事業「思春期のひきこもりをもたらす精神科疾患の実態把握と精神医学的治療・援助システムの構築に関する研究(H19-こころ-一般-010)」平成19-21年度総合研究報告書. 2010. http://www.ncgmkohnodai.go.jp/pdf/jidouseishin/22ncgm_hikikomori.pdf
 
16) 高木隆郎ほか. 学校恐怖症の典型像(I). 児童精神医学とその近接領域 1965;6:146-156.
 
17) 鷲見たえ子, 玉井収介, 小林育子. 学校恐怖症の研究. 精神衛生研究 1960;8:27-56.
 
P.266 掲載の参考文献
1) 後藤雅博. ひきこもりケースへの危機介入-緊急時対応の実際と原則. 近藤直司(編著). ひきこもりケースの家族援助. 東京:金剛出版;2001.
 
2) 貝谷久宣ほか. 我が国における社会不安障害の特徴と治療の実際. 臨床精神薬理 2003;6(10):1309-1320.
 
3) 笠原敏彦. 対人恐怖と社会不安障害. 東京:金剛出版;2005.
 
4) 近藤直司ほか. 青年期ひきこもりケースの精神医学的背景について. 精神神経学雑誌 2007;109:834-843.
 
5) 近藤直司ほか. 思春期ひきこもりにおける精神医学的障害の実態把握に関する研究. 厚生労働科学研究(こころの健康科学研究事業)「思春期のひきこもりをもたらす精神科疾患の実態把握と精神医学的治療・援助システムの構築に関する研究」(研究代表者:齊藤万比古)平成21年度研究報告書. 2010.
 
6) 近藤直司ほか. 在宅青年・成人の支援に関する研究-ライフステージからみた青年・成人期PDDケースの効果的支援に関する研究. 厚生労働科学研究(障害保健福祉総合研究事業)「ライフステージに応じた広汎性発達障害者に対する支援のあり方に関する研究」(主任研究者:神尾陽子)平成21年度研究報告書. 2010.
 
7) 厚生労働省. 厚生労働科学研究(こころの健康科学研究事業)「思春期のひきこもりをもたらす精神科疾患の実態把握と精神医学的治療・援助システムの構築に関する研究」(研究代表者:齊藤万比古)平成21年度研究報告書. 2010.
 
8) 鍋田恭孝. 「ひきこもり」と不全型神経症-特に対人恐怖症・強迫神経症を中心に. 精神医学 2003;45(3):247-253.
 
9) 永田利彦ほか. 社会不安障害に対する薬物療法. 精神医学 2004;46(9):933-939.
 
10) 中村敬ほか. 対人恐怖症はどうなったのか-社会不安障害とひきこもりに関連して. 精神科治療学 2006;21(11):1207-1214.
 
11) Rubin KH, Stewart SL. Social withdrawal. In:Mash E, Barkley R( eds). Child Psychopathology. New York:Guilford Press;1996. pp277-307.
 
P.278 掲載の参考文献
1) Black B, et al. Specific phobia, panic disorder, social phobia, and selective mutism. In:Wiener JM, Dulcan MK(eds). Textbook of Child and Adolescent Psychiatry, 3rd edition. Washington DC:American Psychiatric Publishing;2004. pp589-607.
 
2) Compton SN, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents:An evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004;43(8):930-959.
PubMed
3) 傳田健三ほか. 児童・青年期の気分障害に関する臨床的研究. 児童青年精神医学とその近接領域 2001;42:277-302.
 
4) 傳田健三. 子どものうつ病-見逃されてきた重大な疾患. 東京:金剛出版;2002.
 
5) 傳田健三. 小児のうつと不安-診断と治療の最前線. 東京:新興医学出版社;2006.
 
6) Donnelly CL, March JS, Amaya-Jackson L. Pediatric posttraumatic stress disorder. In:Wiener JM, Dulcan MK(eds). Textbook of Child and Adolescent Psychiatry, 3rd edition. Washington DC:American Psychiatric Publishing;2004. pp609-636.
 
7) Freeman JB, et al. Obsessive-compulsive disorder. In:Wiener JM, Dulcan MK(eds). Textbook of Child and Adolescent Psychiatry, 3rd edition. Washington DC:American Psychiatric Publishing;2004. pp575-588.
 
8) Friedberg RD, Friedberg BA, Friedberg RJ. Therapeutic Exercises for Children:Guided Self-Discovery Using Cognitive-Behavioral Techniques. Sarasota, FL:Professional Resource Exchange;2001/長江信和, 元村直靖, 大野裕(訳). 子どものための認知療法練習帳. 大阪:創元社;2006.
 
9) Friedberg RD, Crosby LE. Therapeutic Exercises for Children:Professional Guide. Sarasota, FL:Professional Resource Exchange;2001/長江信和, 元村直靖, 大野裕(訳). 子どものための認知療法練習帳ガイドブック. 大阪:創元社;2008.
 
10) Gail A, Layne AE. Separation anxiety disorder and generalized anxiety disorder. In:Wiener JM, Dulcan MK. Textbook of Child and Adolescent Psychiatry, 3rd edition. Washington DC:American Psychiatric Publishing;2004. pp557-573.
 
11) In-Albon T, Schneider S. Psychotherapy of childhood anxiety disorders:A meta-analysis. Psychother Psychosom 2007;76:15-24.
PubMed
12) 生地新. 子どものうつ病の診断と治療について. ヒューマンサイエンス 2004;15(6):14-17.
 
13) 生地新. 小児・思春期のうつ病に対する精神療法の実際. Prog Med 2009;29:2617-2621.
Medical*Online
14) Watanabe N, et al. Psychotherapy for depression among children and adolescents:A systematic review. Acta Psychiatr Scand 2007;116:84-95.
PubMed
15) Weller EB, Weller RA, Danielyan AK. Mood disorders in prepubertal children. In:Wiener JM, Dulcan MK(eds). Textbook of Child and Adolescent Psychiatry, 3rd edition. Washington DC:American Psychiatric Publishing;2004. pp411-435.
 
16) Weller EB, Weller RA, Danielyan AK. Mood disorders in adolescents. In:Wiener JM, Dulcan MK(eds). Textbook of Child and Adolescent Psychiatry, 3rd edition. Washington DC:American Psychiatric Publishing;2004. pp437-481.
 
P.289 掲載の参考文献
1) Akiskal HS, et al. Bipolar II and anxious reactive "comorbidity":Toward better phenotypic characterization suitable for genotyping. J Affect Disord 2006;96(3):239-247.
PubMed
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision. Washington DC:American Psychiatric Association;2000/高橋三郎, 大野裕, 染矢俊幸(訳). DSM-IV-TR精神障害の分類と診断の手引新訂版. 東京:医学書院;2002. pp137-170.
 
3) Birmaher B, et al. Is bipolar disorder specifically associated with panic disorders in youths? J Clin Psychiatry 2002;63(5):414-419.
PubMed
4) Dickstein DP, et al. Comorbid anxiety in phenotypes of pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2005;15(4):534-548.
PubMed
5) Feske U, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry 2000;157(6):956-962.
 
6) Gaudiano BA, Miller JW. Anxiety disorder comorbidity in bipolar I disorder:Relationship to depression severity and treatment outcome. Depress Anxiety 2005;21(1):71-77.
 
7) Ghaemi SN, et al. Bipolar spectrum disorder:A pilot study. Psychopathology 2004;37(5):222-226.
PubMed
8) Goldstein BI, Levitt AJ. Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders. J Affect Disord 2007;103(1-3):187-195.
 
9) Goodwin RD, Hoven CW. Bipolar-panic comorbidity in the general population:Prevalence and associated morbidity. J Affect Disord 2002;70(1):27-33.
PubMed
10) Henin A, et al. Childhood antecedent disorders to bipolar disorder in adults:A controlled study. J Affect Disord 2007;99(1-3):51-57.
 
11) Henry C, et al. Anxiety disorders in 318 bipolar patients:Prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 2003;64(3):331-335.
PubMed
12) 井崎ゆみ子, 友竹正人, 大森哲郎. 小中学校時に不登校経験があり青年期以降に大うつ病エピソードをきたした3例. 第48回日本児童青年精神医学会総会抄録集. 2007. p168.
 
13) Johnson JG, Cohen P, Brook JS. Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood:A community-based longitudinal investigation. Am J Psychiatry 2000;157(10):1679-1681.
PubMed
14) Keck PE Jr, Strawn JR, McElroy SL. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. J Clin Psychiatry 2006;67(Suppl 1):8-15.
 
15) Kessler RC, et al. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997;27(5):1079-1089.
 
16) Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents:Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995;34(4):454-463.
 
17) MacKinnon DF, et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 2002;159(1):30-35.
PubMed
18) MacQueen GM, et al. Subsyndromal symptoms associated in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003;5(5):349-355.
PubMed
19) Mantere O, et al. Differences in axis I and II comorbidity between bipolar I and II disorders and major depressive disorder. J Clin Psychiatry 2006;67(4):584-593.
PubMed
20) Masi G, et al. A naturalistic study of referred children and adolescents with obsessivecompulsive disorder. J Am Acad Child Adolesc Psychiatry 2005;44(7):673-681.
PubMed
21) Masi G, et al. Clinical and research implications of panic-bipolar comorbidity in children and adolescents. Psychiatry Res 2007;153(1):47-54.
PubMed
22) McElroy SL, et al. Axis I psychiatric comorbidity and its relationship to historical illness variations in 288 patients with bipolar disorder. Am J Psychiatry 2001;158(3):420-426.
 
23) 棟居俊夫. 子どもの双極性障害の薬物療法. 児青医誌 2009;50(4):361-365.
 
24) 棟居俊夫. 青年期の双極性障害. 日本医事新報 2009;4460:58-62.
Medical*Online
25) Otto MW, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006;189(1):20-25.
PubMed
26) Perlis RH, et al. Long-term implications of early onset in bipolar disorder:Data from the first 1,000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004;55(9):875-881.
 
27) Perugi G, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessivecompulsive disorder. J Affect Disord 1997;46(1):15-23.
PubMed
28) Savino M, et al. Affective comorbidity in panic disorder:Is there a bipolar connection? J Affect Disord 1993;28(3):155-163.
 
29) Simon NM, et al. Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res 2003;37(3):187-192.
PubMed
30) Simon NM, et al. Anxiety disorder comorbidity in bipolar disorder patients:Data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004;161(12):2222-2229.
PubMed
31) Wagner KD. Bipolar disorder and comorbid anxiety disorders in children and adolescents. J Clin Psychiatry 2006;67(Suppl 1):16-20.
 
32) Wozniak J, et al. Parsing the comorbidity between bipolar disorder and anxiety disorders:A familial risk analysis. J Child Adolesc Psychopharmacol 2002;12(2):101-111.
PubMed
33) Young LT, et al. Anxious and non-anxious bipolar disorder. J Affect Disord 1993;29(1):49-52.
PubMed
34) Zimmermann P, et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 2009;66(12):1341-1352.
PubMed
35) Zutshi A, et al. Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2006;256(7):428-436.
PubMed

書評

最近チェックした商品履歴

Loading...